The difference between injectable vs oral peptides comes down to bioavailability, and with oral semaglutide drops, technique is everything
Menopausal status and hypo-oestrogen risk : age, menopausal transition symptoms, breastfeeding/postpartum status, oophorectomy, cancer endocrine therapy, etc
If research continues to show GLP-1 drugs can significantly reduce cancer risk, these medications could become a new tool in cancer prevention strategies
These actions collectively contribute to a decrease in appetite, helping individuals consume fewer calories and, consequently, lose weight over time
Studies have also shown that these medications can downregulate pro-inflammatory cytokines, increase the production of neurotrophic factors, and enhance mitochondrial function, all of which contribute to the preservation and protection of neuronal cells
Some other GLP-1 RAs, like liraglutide, call for daily injections